Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 605 followers
Latest posts
Last updated about 12 hours ago
Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B
about 8 hours ago
Pivotal B-Well data show a significant 19% functional cure in the overall...
GSK to showcase long-term outcomes and pipeline expansion with latest oncology research at ASCO and EHA
2 days ago
GSK will present new data from its expanding oncology portfolio and pipeline...
GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk
11 days ago
First RSV vaccine approved for adults aged 18-59 years at increased risk...
GSK enters exclusive collaboration with SBP Group, a market leader in hepatology in China, to accelerate bepirovirsen at launch
17 days ago
Bepirovirsen is a potential first-in-class treatment for chronic hepatitis B, under priority...
GSK presents latest respiratory research to advance patient care at ATS 2026
22 days ago
Patient preference and adherence research highlight potential of long-acting dosing regimens to...
Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA
about 1 month ago
Breakthrough Therapy Designation added to Fast Track Designation, recognising potential for substantial...
GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH
about 1 month ago
Designations recognise potential for efimosfermin to address significant unmet medical need &amp...
TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation
about 1 month ago
Delaware Chancery Court has granted the motion to dismiss filed by AnaptysBio...
Blenrep (belantamab mafodotin) approved in China for treatment of 2L+ relapsed/refractory multiple myeloma
about 1 month ago
As the only anti-BCMA approved in 2L+ multiple myeloma in China, Blenrep...
GSK completes acquisition of 35Pharma Inc.
about 1 month ago
GSK today announced the completion of its previously announced acquisition of 35Pharma...
GSK presents positive data for B7-H4-targeted ADC in gynaecological cancers
about 2 months ago
Promising efficacy and safety profile supports start of five pivotal phase III...